Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-02-01 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE PLESSIS-BOUCHARD (95130), Val-d'Oise
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LEVY TETI : revenue, balance sheet and financial ratios
PHARMACIE LEVY TETI is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE PLESSIS-BOUCHARD (95130),
this company of category PME
shows in 2024 a net income positive of 408 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LEVY TETI (SIREN 790399976)
Indicator
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
408 120 €
221 409 €
582 582 €
430 046 €
175 000 €
139 584 €
171 140 €
176 964 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE LEVY TETI generates positive net income of 408 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 177 k€ -> 408 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
408 120 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 111%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
110.956%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.616%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Debt ratio
203.661
147.062
117.771
80.002
362.973
178.411
156.691
110.956
Financial autonomy
29.438
36.403
42.226
49.799
19.718
33.74
36.846
45.616
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
110.962024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-10 pts over 3 years
In 2024, the debt ratio of PHARMACIE LEVY TETI (110.96) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.62%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+13 pts over 3 years
In 2024, the financial autonomy of PHARMACIE LEVY TETI (45.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1032.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1032.417
Liquidity indicators evolution PHARMACIE LEVY TETI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Liquidity ratio
129.16
138.955
145.914
130.226
260.767
378.993
337.713
1032.417
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
1032.422024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of PHARMACIE LEVY TETI (1032.42) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE LEVY TETI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LEVY TETI is estimated at
5 697 656 €
(range 3 967 758€ - 8 524 020€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3967k€5697k€8524k€
5 697 656 €Range: 3 967 758€ - 8 524 020€
NAF 5 année 2024
Valuation method used
Net Income Multiple
408 120 €
×
14.0x
=5 697 657 €
Range: 3 967 758€ - 8 524 021€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LEVY TETI with other companies in the same sector:
Frequently asked questions about PHARMACIE LEVY TETI
What is the revenue of PHARMACIE LEVY TETI ?
The revenue of PHARMACIE LEVY TETI is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LEVY TETI profitable?
Yes, PHARMACIE LEVY TETI generated a net profit of 408 k€ in 2024.
Where is the headquarters of PHARMACIE LEVY TETI ?
The headquarters of PHARMACIE LEVY TETI is located in LE PLESSIS-BOUCHARD (95130), in the department Val-d'Oise.
Where to find the tax return of PHARMACIE LEVY TETI ?
The tax return of PHARMACIE LEVY TETI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LEVY TETI operate?
PHARMACIE LEVY TETI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart